A qualitative study of insurers' coverage for mifepristone-induced abortion

Gemperli, M.P.; Stewart, F.H.; Phillips, K.A.; Sakowski, J.; Van Bebber, S.; Bergthold, L.

Managed Care Interface 18(3): 26-30 32

2005


ISSN/ISBN: 1096-5645
PMID: 15816295
Document Number: 593242
In this qualitative evaluation of 14 U.S. health insurers' coverage policies concerning mifepristone-induced medical abortion, the findings suggest that a significant proportion of health plans do not include evidence-based clinical information obtained from recent research, data, and practice. This omission may hinder the adoption of new, evidence-based protocols for medical abortion by physicians. A model coverage policy that contains comprehensive clinical information regarding appropriate clinical regimens for mifepristone is provided as an example for insurers and others in the field.

Document emailed within 1 workday
Secure & encrypted payments